The Pain in Alzheimer's Disease – Diagnosis and Treatment - reports human trial data
DOI:
https://doi.org/10.12775/QS.2025.42.60936Keywords
dementia, Alzheimer's disease, chronic pain, treatment, pain assessment tools, indicator of painAbstract
Dementia diseases, led by Alzheimer's disease (AD), are among the most common and serious conditions affecting the elderly. The number of people suffering from Alzheimer's disease is increasing every year. Among these individuals, a significant portion experiences chronic pain, the diagnosis of which poses a major challenge due to communication difficulties with the patients suffering from Alzheimer's disease. The objective of this publication is to provide an overview of the available methods for diagnosing and treating pain in patients with Alzheimer’s disease. The article presents the studies that utilized neuroimaging diagnostics and scales used to assess the severity and impact of pain on daily functioning, as well as the medications used. Neuroimaging studies indicate that while pain pathways are preserved in the early stages of Alzheimer's disease, the response to pain stimuli diminishes in more advanced stages, potentially necessitating higher doses of analgesics in many AD patients. Effective treatment of chronic pain is crucial for improving the quality of life of patients, yet its diagnosis still presents many challenges due to communication difficulties with these individuals, the lack of precise scales, assessment methods, and the small number of individuals included in the studies.
References
1. Leszek J. Choroba Alzheimera: obecny stan wiedzy, perspektywy terapeutyczne, Polski Przegląd Neurologiczny, 2012, tom 8, nr 3
2. Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chételat G, Teunissen CE, Cummings J, van der Flier WM. Alzheimer's disease. Lancet. 2021 Apr 24;397(10284):1577-1590. doi: 10.1016/S0140-6736(20)32205-4. Epub 2021 Mar 2
3. Scherder EJ, Bouma A. Visual analogue scales for pain assessment in Alzheimer's disease. Gerontology. 2000 Jan-Feb;46(1):47-53. doi: 10.1159/000022133.
4. Domżał TM. Ból przewlekły problemy kliniczne i terapeutyczne, Polski Przegląd Neurologiczny, 2008, tom 4, nr 1
5. van Kooten J, Binnekade TT, van der Wouden JC, Stek ML, Scherder EJ, Husebø BS, Smalbrugge M, Hertogh CM. A Review of Pain Prevalence in Alzheimer's, Vascular, Frontotemporal and Lewy Body Dementias. Dement Geriatr Cogn Disord. 2016;41(3-4):220-32. doi: 10.1159/000444791. Epub 2016 May 10
6. Cao S, Fisher WD, Yu T, Dong H. The link between chronic pain and Alzheimer’s disease, Cao et al. Journal of Neuroinflammation (2019) 16:204. doi: 10.1186/s12974-019-1608-z.
7. Scherder EJ, Eggermont L, Plooij B, Oudshoorn J, Vuijk PJ, Pickering G, Lautenbacher S, Achterberg W, Oosterman J. Relationship between chronic pain and cognition in cognitively intact older persons and in patients with Alzheimer's disease. The need to control for mood. Gerontology. 2008;54(1):50-8. doi: 10.1159/000113216. Epub 2008 Jan 10
8. Cole LJ, Farrell MJ, Duff EP, Barber JB, Egan GF, Gibson SJ. Pain sensitivity and fMRI pain-related brain activity in Alzheimer's disease. Brain. 2006 Nov;129(Pt 11):2957-65. doi: 10.1093/brain/awl228. Epub 2006 Sep 2
9. Husebo BS, Achterberg W, Flo E. Identifying and Managing Pain in People with Alzheimer's Disease and Other Types of Dementia: A Systematic Review. CNS Drugs. 2016 Jun;30(6):481-97. doi: 10.1007/s40263-016-0342-7
10. Herr K, Coyne PJ, Ely E, Gélinas C, Manworren RCB. Pain Assessment in the Patient Unable to Self-Report: Clinical Practice Recommendations in Support of the ASPMN 2019 Position Statement. Pain Manag Nurs. 2019 Oct;20(5):404-417. doi: 10.1016/j.pmn.2019.07.005. Epub 2019 Oct 12.
11. Manfredi PL, Breuer B, Wallenstein S, Stegmann M, Bottomley G, Libow L. Opioid treatment for agitation in patients with advanced dementia. Int J Geriatr Psychiatry. 2003 Aug;18(8):700-5. doi: 10.1002/gps.906.
12. Wordliczek J, Woroń J, Targońska-Stępniak B, Tarnacka B, Malec-Milewska M. Leczenie bólu zapalnego – problem interdyscyplinarny widziany oczami reumatologa, neurologa, rehabilitanta, specjalisty medycyny bólu i farmakologa klinicznego Treatment of inflammatory pain – an interdisciplinary problem from the perspective of a rheumatologist, neurologist, physiotherapist, pain specialist and clinical pharmacologist, Ból 2018, Tom 19, Nr 4, s. 11–26, DOI: 10.5604/01.3001.0013.2753
13. Gutysz-Wojnicka A, Dyk D, Ozga D, Cudak E. Pozawerbalne wskaźniki bólu u pacjentów nieprzytomnych, wentylowanych mechanicznie Non-verbal indicators of pain in unconscious, mechanically ventilated patients
14. Achterberg WP, Pieper MJ, van Dalen-Kok AH, de Waal MW, Husebo BS, Lautenbacher S, Kunz M, Scherder EJ, Corbett A. Pain management in patients with dementia. 2013:8:1471-82. doi: 10.2147/CIA.S36739. Epub 2013 Nov 1
15. Erdal A, Flo E, Aarsland D, Selbaek G, Ballard C, Slettebo DD, Husebo BS. Tolerability of buprenorphine transdermal system in nursing home patients with advanced dementia: a randomized, placebo-controlled trial (DEP.PAIN.DEM) 2018 May 16:13:935-946. doi: 10.2147/CIA.S161052. eCollection 2018
16. Chen K, Li H, Yang L, Jiang Y, Wang Q, Zhang J, He J. Comparative efficacy and safety of antidepressant therapy for the agitation of dementia: A systematic review and network meta-analysis 2023 Mar 3:15:1103039. doi: 10.3389/fnagi.2023.1103039
17. Lawn T, Aman Y, Rukavina K, Sideris-Lampretsas G, Howard M, Ballard C, Ray Chaudhuri K., Malcangio M. Pain in the neurodegenerating brain: insights into pharmacotherapy for Alzheimer disease and Parkinson disease 2020 Nov 24;162(4):999–1006. doi: 10.1097/j.pain.00000000000021
18. Liao YJ, Jao YL, Berish D, Hin AS, Wangi K, Kitko L, Mogle J, Boltz M. Systematic Review of Barriers and Facilitators of Pain Management in Persons with Dementia 2023 May;24(5):730-741. doi: 10.1016/j.jpain.2022.12.014. Epub 2023 Jan 9
19. Banks WA. Drug Delivery to the Brain in Alzheimer’s Disease: Consideration of the Blood-brain Barrier 2012 May 15;64(7):629-39. doi: 10.1016/j.addr.2011.12.005. Epub 2011 Dec 17.
20. Wilco A, Lautenbacher S, Husebo B, Erdal A, Herr K. Pain in dementia PAIN Reports 5(1):p e803, January/February 2020. | DOI: 10.1097/PR9.0000000000000803(Eur J Pain 2020 Jan;24(1):192-208. doi: 10.1002/ejp.1477. Epub 2019 Oct 13.
21. Kunz M, Margot W.M de Waal, Wilco P. Achterberg, Gimenez-Llort L, Lobbezoo F, Sampson EL, van Dalen-Kok AH, Defrin R, Invitto S, Konstantinovic L, Oosterman J, Petrini L, van der Steen JT, Strand LI, de Tommaso M, Zwakhalen S, Husebo BS, Lautenbacher S. The Pain Assessment in Impaired Cognition scale (PAIC15): A multidisciplinary and international approach to develop and test a meta-tool for pain assessment in impaired cognition, especially dementia September 2019European journal of pain (London, England) 24(1) DOI:10.1002/ejp.1477
22. Defrin R, Beshara H, Benromano T, Hssien K, Pick CG, Kunz M. Pain Behavior of People with Intellectual and Developmental Disabilities Coded with the New PAIC-15 and Validation of Its Arabic Translation Brain Sci. 2021, 11(10), 1254; https://doi.org/10.3390/brainsci11101254
23. Zwakhalen SM, Hamers JP, Abu-Saad HH, Berger MP. Pain in elderly people with severe dementia: A systematic review of behavioural pain assessment tools Published: 27 January 2006 BMC Geriatrics 2006, 6:3 doi:10.1186/1471-2318-6-3 Received: 26 July 2005 Accepted: 27 January 2006
24. Heller GZ, Manuguerra M, Chow R. How to analyze the Visual Analogue Scale: Myths, truths and clinical relevance Gillian https://doi.org/10.1016/j.sjpain.2016.06.012
25. Scherder EJ , Bouma A. Visual analogue scales for pain assessment in Alzheimer's disease Affiliations Expand PMID: 11111229 DOI: 10.1159/000022133
26. Tousignant-Laflamme Y, Rainville P, Marchand S. Establishing a link between heart rate and pain in healthy subjects: a gender effect. PMID: 15943955. DOI: 10.1016/j.jpain.2005.01.351
27. Atee M, Hoti K, Parsons R, Hughes JD. Pain Assessment in Dementia: Evaluation of a Point-of-Care Technological Solution PMID: 28800333 PMCID: PMC5611807 DOI: 10.3233/JAD-170375
28. Zheng Q, Wang X. Alzheimer’s disease: insights into pathology, molecular mechanisms, and therapy. Protein & Cell, Volume 16, Issue 2, February 2025, Pages 83–120, https://doi.org/10.1093/procel/pwae026
29. Ando C, Hishinuma M. Development of the Japanese DOLOPLUS-2: a pain assessment scale for the elderly with Alzheimer's disease. Affiliations Expand PMID: 20860568 DOI: 10.1111/j.1479-8301.2010.00324.x
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Gabriela Prucnal, Karolina Ryba, Martyna Bukała, Kornelia Pudło, Klaudia Zacher, Anna Rakoczy, Patrycja Walkiewicz, Jowita Frydrych, Katarzyna Znamirowska, Karolina Ochyra

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 58
Number of citations: 0